secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-06-05T20:30:16+00:00
Accession:  0001193125-26-259703
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics enters into $17.35M ATM equity distribution agreement with Canaccord Genuity
--------------------------------------------------------------------------------

- Up to $17.35M of common stock may be sold at-the-market through Canaccord Genuity as agent.
- Commission of 3.0% of gross proceeds plus $75,000 expense reimbursement to Agent.
- Proceeds intended for general corporate purposes and working capital.
- Sales may be made on Nasdaq Capital Market under Rule 415; no obligation to sell shares.
- Offering terminates upon sale of all shares or termination of Distribution Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526259703/0001193125-26-259703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526259703/pstv-20260601.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-259703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer